Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8429
|
pubmed:dateCreated |
1985-4-18
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
16
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
646
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2857989-Anti-Infective Agents,
pubmed-meshheading:2857989-Child,
pubmed-meshheading:2857989-Cystic Fibrosis,
pubmed-meshheading:2857989-Enoxacin,
pubmed-meshheading:2857989-Humans,
pubmed-meshheading:2857989-Male,
pubmed-meshheading:2857989-Naphthyridines,
pubmed-meshheading:2857989-Pseudomonas Infections
|
pubmed:year |
1985
|
pubmed:articleTitle |
Use of enoxacin in a patient with cystic fibrosis.
|
pubmed:publicationType |
Letter,
Case Reports
|